FAH and metabolic disease: Tyrosinemia type 1 (TT1, OMIM#276700) is a rare inborn metabolic disease, caused by a deficiency of the fumarylacetoacetate hydrolase (FAH) enzyme, which disrupts the catabolic pathway of tyrosine (Tyr).